Surrozen, Inc. (SRZN)
NASDAQ: SRZN · Real-Time Price · USD
21.87
-0.13 (-0.59%)
At close: Aug 5, 2026, 4:00 PM EDT
21.95
+0.08 (0.37%)
After-hours: Aug 5, 2026, 4:00 PM EDT
Surrozen Market Cap
Surrozen has a market cap or net worth of $253.92 million as of August 5, 2026. Its market cap has increased by 171.06% in one year.
Market Cap
253.92M
Enterprise Value
146.94M
1-Year Change
171.06%
Ranking
Category
Stock Price
$21.87
ChartMarket Cap Chart
Since January 11, 2021, Surrozen's market cap has increased from $120.65M to $253.92M, an increase of 110.45%. That is a compound annual growth rate of 14.30%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 5, 2026 | 253.92M | 20.51% |
| Dec 31, 2025 | 210.69M | 351.80% |
| Dec 31, 2024 | 46.63M | 143.39% |
| Dec 29, 2023 | 19.16M | 10.72% |
| Dec 30, 2022 | 17.31M | -92.33% |
| Dec 31, 2021 | 225.58M | 86.96% |
| Jan 11, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Bicycle Therapeutics | 275.06M |
| Eledon Pharmaceuticals | 269.79M |
| ALX Oncology Holdings | 265.09M |
| InflaRx | 262.18M |
| Entrada Therapeutics | 260.88M |
| ProQR Therapeutics | 258.25M |
| Orchestra BioMed Holdings | 255.69M |
| MacroGenics | 247.90M |